STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,000 | -60.0% | 500 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $5,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $5,000 | -37.5% | 500 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $8,000 | +33.3% | 500 | 0.0% | 0.00% | +100.0% |
| Q1 2019 | $6,000 | +20.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $5,000 | -37.5% | 500 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $8,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $8,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $8,000 | +14.3% | 500 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $7,000 | +16.7% | 500 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $6,000 | +20.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $5,000 | +25.0% | 500 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $4,000 | -81.8% | 500 | -75.0% | 0.00% | -88.9% |
| Q3 2016 | $22,000 | +266.7% | 2,000 | +300.0% | 0.01% | +350.0% |
| Q2 2015 | $6,000 | -79.3% | 500 | -75.0% | 0.00% | -80.0% |
| Q1 2015 | $29,000 | – | 2,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 475,200 | $6,877,000 | 3.03% |
| Avoro Capital Advisors LLC | 475,000 | $6,873,000 | 2.64% |
| VHCP Management, LLC | 451,400 | $6,532,000 | 1.50% |
| Sio Capital Management, LLC | 140,000 | $2,026,000 | 1.15% |
| Opus Point Partners Management, LLC | 75,000 | $1,085,000 | 0.91% |
| Eventide Asset Management | 620,200 | $8,974,000 | 0.68% |
| Telemetry Investments, L.L.C. | 55,000 | $796,000 | 0.44% |
| Healthcare Value Capital, LLC | 25,000 | $362,000 | 0.40% |
| TFS CAPITAL LLC | 259,916 | $3,761,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 672,562 | $9,732,000 | 0.14% |